Numbers

The Numbers

Guan Chong is a cocoa-bean processor — a commodity conversion business whose reported profits are genuine but whose cash flows swing violently with cocoa prices and inventory positions. The past three years show the trap: revenue nearly tripled (RM 4.4B to RM 14.9B) as cocoa prices exploded, GAAP earnings surged then collapsed, and the balance sheet absorbed a RM 2B+ working-capital shock to finance the inventory. The single metric that reprices this stock is net debt / EBITDA — it drove the 57% peak-to-trough sell-off in 2024–25 and it is the metric the market will watch next.

A. Snapshot

Price (RM)

0.84

Market Cap (RM M)

2,289

Quality Score (/100)

Fair Value (RM)

2.49

Revenue FY25 (RM M)

14,923

Quality Score blends balance-sheet health, growth, profitability, and momentum (0–100). Fair Value is the model's estimate of intrinsic value per share; current price of RM 0.835 sits 66% below the RM 2.49 long-term fair value but 42% below the more cautious 12-month estimate of RM 1.44 — reflecting a business the market thinks is worth more long term than the next 12 months suggest.

B. Quality scorecard — will it still be here in ten years?

No Results

The scorecard tells a split story. Growth, momentum and profitability all rank top-tier, but the balance-sheet score is the worst sub-rank at 3 of 10 and Altman Z has just exited the distress zone. Earnings quality is clean (Beneish M well below the -1.78 threshold), but cash flows are not — which the next section makes plain.

C. Revenue and earnings power — 18-year view

Revenue nearly tripled from 2022 to 2025 almost entirely on cocoa price inflation, not volume gains. Net margin tells the contradiction: even as revenue hit a record, FY2025 net margin fell to 1.52% — the lowest reading since 2016 — as interest expense on inventory-funding debt consumed the operating income.

D. Recent quarterly trajectory

Revenue peaked in 1Q25 at RM 4.3B and has fallen every quarter since — cocoa prices have normalized and pass-through hedging losses are compressing spreads. Net income is already back down to RM 43M in 4Q25, versus RM 213M in 4Q24. The revenue-driven re-rating is already reversing.

E. Cash generation — are the earnings real?

**Cash conversion is the single most important chart on this page.** Trailing-5-year cumulative net income was +RM 929M, cumulative FCF was **-RM 4.1B**. Reported profits are effectively re-invested into inventory at volatile cocoa prices. When cocoa spikes, working capital drinks every cent of earnings plus billions in fresh debt; when cocoa eases (2025), the reverse happens and FCF swings violently positive (+RM 884M). An investor cannot value this business on steady-state FCF.

F. Capital allocation

FY2025 is the telling year — after absorbing a RM 2B debt raise in 2024 to buy inventory, management used the cocoa-price normalization to pay down RM 914M of debt, their largest single-year deleveraging. Dividends remain negligible (payout under 20% even in good years), buybacks effectively zero. This is a company that reinvests everything into working capital.

G. Balance sheet health

Leverage is the real swing factor. Net-debt-to-EBITDA peaked above 5x in 2023–24 and still sits near 4.9x — well above the 2x band investors expect of a commodity processor. Interest expense was RM 337M in FY2025, 53% of operating income. Every 100 basis points of rate movement wipes RM 32M of pretax profit — roughly 11% of net income. Altman Z sits at 2.93, just inside the grey zone.

H. Valuation — now vs its own 18-year history

Current P/E

8.8

18y Median P/E

11.0

5y Median P/E

17.7

Current P/E of 8.8x sits below the 18-year median of 10.9x and well below the 5-year median of 17.7x — the stock has de-rated roughly 50% from its 2021–23 boom-era multiples. EV/EBITDA of 8.1x also sits below its 10.9x long-run median. On multiples alone this is the cheapest the stock has been since 2018 — but 2018 was followed by earnings normalizing back to trend, not collapsing, which is the open question today.

Book value per share has compounded steadily from RM 0.19 to RM 0.83 (a 16% CAGR). EPS, however, is erratic: the RM 0.157 print in FY2024 was the outlier, and FY2025 of RM 0.083 is closer to a through-the-cycle run-rate. FCF per share is the broken line — only 3 of the last 10 years positive.

J. Peer comparison

No Results

GCB trades at a clean 40% discount to Barry Callebaut — the global cocoa-processing peer — on both P/E and EV/EBITDA. That gap has always existed (GCB runs with more leverage, less scale, and lower margins), but the current spread is wider than normal. The discount narrows only if GCB's margin profile and leverage both move toward the global peer.

K. Fair-value range

No Results

The Fair Value estimate of RM 2.49 assumes normalization of both cocoa prices and margins — a bull case. The 12-month estimate of RM 1.44 is closer to the base case: it assumes multiple-mean-reversion without a full margin recovery. Consensus analyst target of RM 1.53 aligns with this base.

What the numbers say

Confirm: Guan Chong is a volume-scaled cocoa grinder with genuine operating leverage to cocoa prices — FY2024's RM 429M net income was real, and the company's cash came back hard in FY2025 after working capital released. Book value has compounded at 16% a year for a decade.

Contradict: The narrative that this is a "cheap growth story" is wrong. Revenue growth is cocoa-price growth, not volume growth — and the 5-year cumulative FCF is negative RM 4.1B despite positive cumulative earnings. The market is right to discount GAAP profits here.

Watch: Net debt / EBITDA through FY2026 quarterly prints. If it breaks back above 5x, the stock retests RM 0.55. If it glides toward 3x with margins stable, RM 1.25–1.50 is reachable — matching consensus and the 12-month Fair Value. Cocoa price direction and the CFO/NI ratio each quarter are the leading indicators.